The Veh/CIS group also displayed increased NF-κB p65 activation in the tumors compared to the Veh/Veh (p = 0.42), BARD/Veh (p = 0.26), and BARD/CIS (p = 0.23) groups (Fig. S3C). Here, NFKB1 is linked to in situ carcinoma.